Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a transaction on February 9, 2012, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, they acquired a total of 4 Ordinary shares (2 shares via personal contribution and 2 shares via the Company's matching element) at a price of 1397.64 pence per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share acquisition in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the share price of 1397.64 pence per Ordinary share on February 9, 2012.
- Confirm the total number of shares acquired (4 shares) by Mr. P C Thomson and Mrs. K Thomson under the ShareReward Plan.
- Note that this filing does not contain financial performance data for the period.